Iovance Biotherapeutics (IOVA) R&D US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D, bln rub | 166.0 | 201.7 | 259.0 | 294.8 | 344.1 | 341.1 | |||
Changes by years, y/y, % | +66% | +22% | +28% | +14% | +17% | +28.1% |
Iovance Biotherapeutics. R&D, bln rub
Iovance Biotherapeutics. R&D, changes, %
Iovance Biotherapeutics. R&D, sum by quarters, bln rub
Iovance Biotherapeutics (IOVA) R&D US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
R&D, bln rub | 82.7 | 86.3 | 87.5 | 87.5 | 79.8 | 341.1 | ||
Changes by years, y/y, % | +21% | +18% | +21% | +9% | -4% | |||
Changes by quarters, q/q, % | +3% | +4% | +1% | 0% | -9% |